These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1596898)

  • 1. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.
    Biegel JA; Burk CD; Barr FG; Emanuel BS
    Cancer Res; 1992 Jun; 52(12):3391-5. PubMed ID: 1596898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No preferential parent of origin for the isochromosome 17q in childhood primitive neuroectodermal tumor (medulloblastoma).
    Biegel JA; Wentz E
    Genes Chromosomes Cancer; 1997 Feb; 18(2):143-6. PubMed ID: 9115964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.
    Thomas GA; Raffel C
    Cancer Res; 1991 Jan; 51(2):639-43. PubMed ID: 1670763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
    von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
    Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.
    Raffel C; Gilles FE; Weinberg KI
    Cancer Res; 1990 Feb; 50(3):587-91. PubMed ID: 1967549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
    Pietsch T; Koch A; Wiestler OD
    Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
    Cote RJ; Jhanwar SC; Novick S; Pellicer A
    Cancer Res; 1991 Oct; 51(19):5410-6. PubMed ID: 1913660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
    Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
    Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
    J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular abnormalities in pediatric embryonal brain tumors--analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22.
    Zakrzewska M; Rieske P; Debiec-Rychter M; Zakrzewski K; Polis L; Fiks T; Liberski PP
    Clin Neuropathol; 2004; 23(5):209-17. PubMed ID: 15581023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
    Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
    Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion within the D17S34 locus in a primitive neuroectodermal tumor.
    Haataja L; Raffel C; Ledbetter DH; Tanigami A; Petersen D; Heisterkamp N; Groffen J
    Cancer Res; 1997 Jan; 57(1):32-4. PubMed ID: 8988035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
    Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
    Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
    Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
    DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
    Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
    Emadian SM; McDonald JD; Gerken SC; Fults D
    Clin Cancer Res; 1996 Sep; 2(9):1559-64. PubMed ID: 9816333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Karyotypic evolution pathways in medulloblastoma/primitive neuroectodermal tumor determined with a combination of spectral karyotyping, G-banding, and fluorescence in situ hybridization.
    Cohen N; Betts DR; Tavori U; Toren A; Ram T; Constantini S; Grotzer MA; Amariglio N; Rechavi G; Trakhtenbrot L
    Cancer Genet Cytogenet; 2004 Feb; 149(1):44-52. PubMed ID: 15104282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.